Pronađeno: 1-2 / 2 radova

Autori: Pemmaraju Naveen

>> Filter: Samo Article i Review

Naslov TRANSFORM-1 phase 3 study: efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis (Article)
Autori Pemmaraju Naveen  ...  Bogdanovic Andrija D  ...  (broj koautora 29) 
Info BLOOD, (2026), vol. 148 br. 16, str. 2029-2042
Projekat AbbVie; US Department of Defense; National Cancer Institute, National Institutes of Health [P30CA016672]; MD Anderson Cancer Center Support Grant shared resources [P30CA016672]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis (Meeting Abstract)
Autori Pemmaraju Naveen  ...  Bogdanovic Andrija D  ...  (broj koautora 24) 
Info BLOOD, (2023), vol. 142 br. , Suppl. 1, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX